BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53

Go back to BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53

BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results

February 23, 2017 4:01 PM EST

SAN RAFAEL, Calif., Feb. 23, 2017 /PRNewswire/ --

Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

Three Months EndedDecember 31,

Twelve Months EndedDecember 31,

2016

2015

% Change

... More